Editor's Note
The "Price" of Information M. Jane Heinig, PhD, IBCLC Every day, lactation consultants must make decisions about which methods of assessment and intervention are best suited to their clients' needs. To ensure that these decisions reflect the latest in evidence-based practice, lactation consultants may consult primary research studies, reviews, notes from presentations at conferences, and information provided by the manufacturers of breastfeeding equipment and supplies. However, in the past decade, the line between research and marketing has grown increasingly blurred as more and more research studies are completely funded or heavily supported by commercial interests. Ties to industry funding among researchers, reviewers, and institutions have resulted in an outcry of concern among health care professionals and the public, particularly in the area of medicine. [1] [2] [3] [4] [5] In response, a global forum was convened in Poland last year to allow researchers and institutional representatives to explore and discuss the potential effects of conflict of interest in science. 6 Many institutions have generated rules related to the acceptability and reporting of these ties, 7 and journals have developed policies related to the disclosure of competing interests by authors so that readers may be informed and make their own decisions about the credibility of research findings. With shrinking government budgets in many countries throughout the world, it is not likely that we will see a substantial increase in noncommercial funding for research anytime soon. Therefore, we need to understand how these potential influences may affect us, as health professionals and as individuals.
There was a time when scientific research was funded predominantly by government and military agencies. Scientists worked independently from commercial interests as many basic discoveries were being made. As research moved into areas with potential for industrial and consumer applications, it was natural that a greater proportion of funding would come from industrial groups, especially after a tightening global economy reduced the availability of funding from other sources. There were advantages for researchers to work with industrial groups, such as receiving adequate funding, with less paperwork and wait time than with government granting agencies. Similarly, companies benefited through these partnerships by expanding their capacities to develop and refine technologies and, ultimately, new products. Further, the reputations of the researchers or institutions involved assisted corporations in establishing credibility for their products and findings. Academic-industrial partnerships were perceived as an opportunity to improve and streamline the scientific process, promoting rapid discovery and technological advancement. However, given that companies' interests necessarily promote their own advancement, researchers and the media have questioned these partnerships as negatively affecting the objectivity that is a hallmark of the scientific method.
Published reports have shown that authors of industrysponsored research are more likely to report a positive effect of a product or intervention than those who are independently funded. [8] [9] [10] Although this is a crude assessment of industry influence, these publications provide some evidence that science may be shaped by these partnerships, if only by the possibility that industry may fund only studies it perceives as having the greatest chance of showing positive results.
Beyond the researchers themselves, industry ties may also influence others who are involved in the scientific process, such as members of institutional review boards who approve study protocols, editors and members of the editorial review boards of scientific journals who make decisions about publication, reviewers and abstractors who are involved in writing reviews of the literature, "third-party" associations that may be heavily sponsored by industry to evaluate and disseminate research reports, 11 and research institutions. Therefore, industrial influence may result in control over the design and scope of research projects as well as the dissemination of findings, even if businesses do not directly fund any projects.
In a recent article in the Journal of the American Medical Association, there is an extensive discussion related to industry ties to research institutions. 12 The article describes (1) the various forms of partnerships that have been formed between businesses and research institutions and (2) the need to restore public confidence in the scientific community and guidelines to do so. The authors state that there is no justification for ties between industry and members of institutional review boards or editorial review boards and that if conflicts of interest exist, the particular members affected must excuse themselves from the process. The authors also indicate that there must be clear justification showing that associations between research institutions and industry play a greater beneficial role than merely as channels for funding. They also recommend that authors submitting articles for publication should be required to state not only their own potential conflicts of interest but also any competing interests that may exist for their institutions.
Although it might be tempting to decide that all research funded by industry is suspect or that disclosure prevents misleading or biased findings, the truth is most likely somewhere in between. Bias and misinterpretation can exist whether or not a study is commercially funded, and important research can come from industry. The most common strategy to combat such concerns is to require the disclosure of competing interests in all steps of the scientific process, particularly at publication. The belief is that as long as the interests are disclosed, it is up to the reader to decide whether or not he or she believes that these interests make the study suspect. In a study recently published in the British Medical Journal (BMJ), participants were sent an article that they were asked to critically read and comment on. Some of the participants were sent a copy of the article that stated that there were no competing interests, and others were sent a copy that stated that there were competing interests. Readers receiving the copy listing competing interests found the study to be "less interesting, relevant, valid, and believable" than those receiving the alternate copy, 13 indicating that BMJ readers were generally skeptical of industry-sponsored research regardless of study design and outcomes. It is likely that this finding would be also true for lactation consultants, especially for studies funded by pharmaceutical or infant food manufacturers. Skepticism is often appropriate, but the outright rejection of such studies should involve more caution. Although we must always consider the source of information when considering its validity, our biases should never prevent us from learning about ways to improve our practice.
There is nothing new about industry using research findings to support the sale of products and services. In today's society, advertisements in print and on radio and television are rife with references to clinical studies. Professionals are bombarded by these advertisements too, in their journals and other professional materials. Conference exhibits and presentations and "free" gifts are also used by industry to encourage professionals to use or recommend its products. The breastfeeding community has long criticized the pharmaceutical and medical communities for attending lavish, industrysponsored conferences and accepting gifts, seeing both practices as intrinsically influential. As lactation professionals increase in visibility and responsibility, we have seen more of these marketing methods directed toward our community. As a profession, we are in a position to create our own standards to balance our need for products and related information with our concerns about bias and undue influence from industry. We invite your comments on this issue and hope that the pages of JHL may serve as a venue for constructive discussion. Industry funding for research and marketing is likely to expand in the next decade. It is imperative that we, as health care professionals, remain informed and objective both because of, and in spite of, these practices.
